This year has been one for the books in medicine. From Ozempic’s expanded role in protecting failing kidneys to long‑acting ...
In 2025, drug approvals widen treatment options for chronic diseases, infections and pain, including Ozempic kidney ...
Kymera Therapeutics receives US FDA Fast Track Designation for KT-621, an oral STAT6 degrader to treat atopic dermatitis: Watertown, Massachusetts Saturday, December 13, 2025, 18: ...
So, Regeneron's revenue rose 1.9% from $3.68 billion in Q2 2025 to $3.75 billion, beating consensus estimate by $160 million ...
Company to host video conference call and webcast at 8:00 a.m. ET on Monday, December 8, 2025WATERTOWN, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) ...
Fast Track designation supported by positive results from the KT-621 BroADen Phase 1b atopic dermatitis (AD) patient trial KT-621 BROADEN2 Phase ...
Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
KT-621 achieved deep STAT6 degradation across both the 100 mg and 200 mg dose groups tested, with median reductions of 94% and 98% in skin and blood, respectively, demonstrating strong translation ...
The squirts. Toilet tornados. Fecal fireworks. Watery stools. A volcanic eruption of the butt variety. Whatever you call it, diarrhea sucks. And while anything can tick off your tummy, from bacteria ...
Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...
Arno Kroner, DAOM, LAc, operates a private practice in Santa Monica where he specializes in acupuncture, herbal medicine, and integrative medicine. OTC pain relievers like Tylenol and ibuprofen can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback